Regeneron Announces Upcoming 2013 Investor Conference Presentations

TARRYTOWN, N.Y., Nov. 1, 2013 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management presentations at the following investor conferences:

  • Credit Suisse 2013 Healthcare Conference at 12:00 p.m. Eastern Time (10:00 a.m. Mountain Time) on Tuesday, November 12, 2013
  • Deutsche Bank 2013 BioFEST at 1:05 p.m. Eastern Time on Monday, December 2, 2013
  • Piper Jaffray 25th Annual Healthcare Conference at 8:30 a.m. Eastern Time on Tuesday, December 3, 2013

The sessions may be accessed through the Company's web site, www.regeneron.com, on the 'Events and Presentations' page.  Archived versions of the presentations will be available for 30 days.

About Regeneron Pharmaceuticals
Regeneron is a leading science-based biopharmaceutical company based in Tarrytown, New York that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.  Regeneron markets medicines for eye diseases, colorectal cancer, and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including hypercholesterolemia, oncology, rheumatoid arthritis, asthma, and atopic dermatitis.  For additional information about the company, please visit www.regeneron.com.

Contact Information:




Manisha Narasimhan, Ph.D.     

Peter Dworkin

Investor Relations                

Corporate Communications                                                  

914.847.5126                      

914.847.7640             

manisha.narasimhan@regeneron.com        

peter.dworkin@regeneron.com

SOURCE Regeneron Pharmaceuticals, Inc.



RELATED LINKS
http://www.regeneron.com

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.